In vivo evaluation of tau pathologies in patient with progressive supranuclear palsy and healthy subjects with [11C]PBB3-PET
Objective: This study was aimed at evaluating pathological tau accumulations in the brains of patients with progressive supranuclear palsy (PSP) and young and old healthy…Feasibility and preliminary outcomes of an interdisciplinary home visit program for patients with advanced Parkinson’s disease
Objective: 1) To demonstrate the feasibility of an interdisciplinary home visit program (HVP) for advanced Parkinson's disease (PD) providing expert, interdisciplinary care directly to homebound…Inferring the causal interplay of motor related brain areas in the aging brain: A dynamic causal modeling (DCM) approach
Objective: To investigate the causal interplay of brain areas during the performance of a complex bimanual motor task in young and elderly subjects. Background: Coordination…The value of preference-based measures of quality of life in people with Parkinson’s: A systematic review
Objective: To systematically review and assess the use and value of preference-based quality of life (QoL) measures in Parkinson's. Background: Preference-based QoL measures are used…When and why patients with Parkinson’s disease become bed ridden
Objective: To elucidate the influence of age, disease duration, and complicated medical and social conditions as the risk factors to predict disease progression. To this…Treating Parkinson’s 2015–A nationwide survey of treatment responses and complications in 1000 Irish patients with Parkinson’s disease
Objective: To collect real-life data from a large cohort with Parkinson's disease (PD), with particular emphasis on drug regimens, motor complications, and quality of life…Dopaminergic and metabolic network activities in onset-related subtypes of Parkinson’s disease: A dual-tracer positron emission tomography study
Objective: The current study investigated the differences of dopaminergic and metabolic patterns between the young-onset subtype of Parkinson's disease (YOPD) and the late-onset subtype (LOPD)…Quality of life and living with Parkinson’s in Ireland
Objective: (1) Assess the quality of life (QoL) for people with Parkinson's and explore associations between (QoL) and demographics (2) Investigate incidence of depression and…Tracking Parkinson’s disease over 2-6 years with MRI
Objective: To track Parkinson's progression over 2-6 years using global MRI measures. Background: Parkinson's is associated with accelerated brain atrophy, but the relative contribution of…Broadening the evaluative scope of quality of life in Parkinson’s: Testing the construct validity of the ICECAP-O instrument
Objective: To test the construct validity of ICECAP-O in Parkinson's and explore its relationship with the EQ-5D and the PDQ-39. Background: Parkinson's significantly affects patients'…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.